A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis.
Bourdette DN, Edmonds E, Smith C, Bowen JD, Guttmann CR, Nagy ZP, Simon J, Whitham R, Lovera J, Yadav V, Mass M, Spencer L, Culbertson N, Bartholomew RM, Theofan G, Milano J, Offner H, Vandenbark AA.
Bourdette DN, et al. Among authors: simon j.
Mult Scler. 2005 Oct;11(5):552-61. doi: 10.1191/1352458505ms1225oa.
Mult Scler. 2005.
PMID: 16193893
Clinical Trial.